Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Lipid Metabolism Disorders » Dyslipidemias » Hyperlipidemias » Hypertriglyceridemia
Description
A condition of elevated levels of TRIGLYCERIDES in the blood. MeSH
Hierarchy View
Subtype Terms (3)
Hyperlipoproteinemia Type IV
7 drugs (4 approved, 3 experimental)
Hyperlipoproteinemia Type V
4 drugs (1 approved, 3 experimental)
Hypertriglyceridemic Waist
1 approved drug
Other Experimental Indicated Drugs (31)
Organization Involved with Phase 4 Indications (48)
Birjand University of Medical Sciences
Chinese Academy of Medical Sciences
Dnipropetrovsk State Medical Academy
Eastern Virginia Medical School
National Center for Complementary and Integrative Health (NCCIH)
National Heart Foundation, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Oregon Health and Science University
People's Liberation Army of China
Rio de Janeiro State University
Rundo International Pharmaceutical Research & Development Co.,Ltd.
Organization Involved with Phase 3 Indications (59)
Organization Involved with Phase 1 Indications (19)
Organization Involved with Other Experimental Indications (45)
China Academy of Chinese Medical Sciences
Clinical Research Institute HUCH Ltd
Hoosier Cancer Research Network
Intermountain Research and Medical Foundation
Los Angeles Biomedical Research Institute
Maine Center for Lipids and Cardiovascular Health
National Center for Research Resources (NCRR)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.